Results 131 to 140 of about 10,075 (184)

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study. [PDF]

Hum Vaccin Immunother, 2023
Porntharukchareon T, Chartisathian W, Navinpipat M, Samdaengpan C, Cheirsilpa K, Lueprasitsakul A, Worawichawong S, Muangsillapasart V, Pumuthaivirat P, Dechates B, Sirisreetreerux S, Siripongboonsitti T, Rangsrisaeneepitak V, Jirawattanapalin K, Tawinprai K.   +14 more
europepmc   +1 more source

Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome

Neurological Sciences, 2022
Madhusudan Tapdia, Anand Kumar, Varun Kumar Singh, Abhishek Pathak, Deepika Joshi   +4 more
openaire   +2 more sources

Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report. [PDF]

IDCases, 2023
Shateri Amiri B, Radkhah H, Taslimi R, Shahbazi Dastjerdi Z, Khadembashiri MM, Gholizadeh Mesgarha M, Rahimipour Anaraki S.   +6 more
europepmc   +1 more source

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply [PDF]

The Lancet, 2020
Voysey, Merryn, Pollard, Andrew J
openaire   +2 more sources

Eculizumab discontinuation in a patient with atypical hemolytic uremic syndrome after ChAdOx1 nCoV-19 vaccination. [PDF]

Clin Nephrol Case Stud, 2023
Roldão M, Ferrer F, Lopes K.
europepmc   +1 more source

Anti-N-methyl D-aspartate Receptor Encephalitis Following ChAdOx1 nCoV-19 Vaccination: A Case Report. [PDF]

Arch Iran Med, 2023
Liyaghatdar Z, Rahimkhani A, Liaghatdar A.   +2 more
europepmc   +1 more source

Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination. [PDF]

J Fr Ophtalmol, 2023
Rujkorakarn P, Patamatamkul S.
europepmc   +1 more source

Identification of novel genetic biomarkers for ChAdOx1 nCoV-19 mediated immunogenicity. [PDF]

Front Immunol
Chou WH, Chang CM, Ting J, Lin MR, Liao HN, Chou YC, Wei CY, Chi HH, Ho SY, Luo WT, Tsai CL, Chao CH, Chen LC, Wu TH, Liu WC, Nguyen QA, Chang HW, Hung CS, Hong SY, Wang JC, Hsiao SH, Chang WC.   +21 more
europepmc   +1 more source

Impaired antibody responses to heterologous ChAdOx1 nCoV-19 and BNT162b2 vaccination in individuals with type 2 diabetes. [PDF]

Sci Rep
Saenwongsa W, Kingpha S, Saythanu P, Sopila S, Lertmemongkolchai G, Kewcharoenwong C.   +5 more
europepmc   +1 more source

MassIVE MSV000086998 -site-specific glycosylation analysis of the ChAdOx1 nCoV-19 derived Spike protein

Site-specific glycosylation analysis of the ChAdOx1 nCoV-19 derived Spike protein. Raw files for both the cleaved (S1/S2) and uncleaved (S0) protein are included. [doi:10.25345/C55N6W] [dataset license: CC0 1.0 Universal (CC0 1.0)]
Crispin, Max
core   +1 more source